Treatment of primary central nervous system lymphoma with a combination of intraventricular administration of rituximab and systemic chemotherapy.

被引：0
|
作者：
Wang, Shujie
Zhang, Wei
Lian, Wei
Wu, Yongji
Zou, Nong
Zhu, Tienan
Zhou, Daobin
Xu, Ying
Shen, Ti
Zhao, Yongqiang
机构：
[1] Beijing Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China
[2] Beijing Union Med Coll Hosp, Dept Neurosurg, Beijing, Peoples R China
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4695
引用
收藏
页码：256B / 256B
页数：1
相关论文
共 50 条
  • [31] Primary central nervous system lymphoma: Results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy: Final report
    Juergens, A.
    Pels, H.
    Glasmacher, A.
    Schulz, H.
    Fliessbach, K.
    Linnebank, M.
    Vogt-Schaden, M.
    Reichmann, H.
    Schmidt-Wolf, I. G. H.
    Schlegel, U.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 357 - 357
  • [32] Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy - Final report
    Juergens, A.
    Pels, H.
    Schlegel, U.
    Schmidt-Wolf, I. G. H.
    Glasmacher, A.
    Schulz, H.
    Engert, A.
    Diehl, V.
    Schackert, G.
    Reichmann, H.
    Kroschinsky, F.
    Vogt-Schaden, M.
    Egerer, G.
    Bode, U.
    Schaller, C.
    Deckert, M.
    Fimmers, R.
    Fliessbach, K.
    Klockgether, T.
    Zellner, A.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 : 23 - 24
  • [33] METHOTREXATE-RITUXIMAB TREATMENT IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A CASE REPORT
    Can, E. Saribacak
    Malkan, U.
    Albayrak, M.
    Gunes, G.
    [J]. LEUKEMIA RESEARCH, 2017, 61 : S36 - S36
  • [34] The pharmacokinetics of methotrexate with and without rituximab in the treatment of primary central nervous system lymphoma (PCNSL)
    Rawat, F. R.
    Nolan, A.
    Teo, S. Y.
    Triggs, M.
    Carroll, G.
    Picardo, S.
    Keegan, N. M.
    Mallett, V.
    Ismail, I.
    Hennessy, B.
    Grogan, W.
    Breathnach, O.
    Morris, P.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [35] Meta-analysis of the effect of rituximab in the treatment of primary central nervous system lymphoma
    Yavuz, S.
    Yildirim, M.
    Yazici, G.
    Kaya, V.
    Paydas, S.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [36] Primary Central Nervous System Lymphoma With Systemic Recurrence
    Pandravada, Sasirekha
    Knouse, Phillip
    Bitran, Jacob
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [37] PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA - TREATMENT WITH MULTIAGENT SYSTEMIC AND INTRATHECAL CHEMOTHERAPY WITH RADIATION-THERAPY
    LIANG, BC
    GRANT, R
    JUNCK, L
    SANDLER, HM
    PAPADOPOULOS, SM
    KAMINSKI, MS
    GREENBERG, HS
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1993, 3 (05) : 1001 - 1004
  • [38] Lateral intraventricular primary central nervous system lymphoma (LIPCNSL): a review
    Yang, J.
    Liu, Z.
    Yang, Y.
    Chen, H.
    Xu, J.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2020, 113 (07) : 457 - 464
  • [39] Rituximab treatment in primary angiitis of the central nervous system
    Patel, Shreeya
    Ross, Laura
    Oon, Shereen
    Nikpour, Mandana
    [J]. INTERNAL MEDICINE JOURNAL, 2018, 48 (06) : 724 - 727
  • [40] Treatment of primary central nervous system lymphoma
    Ekenel M.
    DeAngelis L.M.
    [J]. Current Treatment Options in Neurology, 2007, 9 (4) : 271 - 282
12345